|
CSTF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.77962114331376E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.94480012491749E-11 |
| Normal-vs-Stage2 |
5.14939979545659E-10 |
| Normal-vs-Stage3 |
4.4568015944435E-11 |
| Normal-vs-Stage4 |
4.240900E-04 |
| Stage1-vs-Stage2 |
1.126360E-01 |
| Stage1-vs-Stage3 |
3.982300E-02 |
| Stage1-vs-Stage4 |
9.189000E-01 |
| Stage2-vs-Stage3 |
7.291600E-01 |
| Stage2-vs-Stage4 |
4.213600E-01 |
| Stage3-vs-Stage4 |
3.010000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.10267392175956E-12 |
| Normal-vs-AfricanAmerican |
2.31669999961603E-07 |
| Normal-vs-Asian |
1.561400E-01 |
| Caucasian-vs-AfricanAmerican |
9.157000E-01 |
| Caucasian-vs-Asian |
3.411400E-01 |
| AfricanAmerican-vs-Asian |
2.912800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.34854407827379E-12 |
| Normal-vs-Female |
5.85659964968954E-10 |
| Male-vs-Female |
4.203400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.018180E-04 |
| Normal-vs-Age(41-60Yrs) |
4.76649997249723E-09 |
| Normal-vs-Age(61-80Yrs) |
1.75609526920084E-11 |
| Normal-vs-Age(81-100Yrs) |
1.94970000033656E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.567400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.567400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.986000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.895200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.082750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.933200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.486200E-01 |
| Normal-vs-Grade 2 |
1.71339609167376E-11 |
| Normal-vs-Grade 3 |
2.74735789673741E-12 |
| Normal-vs-Grade 4 |
2.614100E-04 |
| Grade 1-vs-Grade 2 |
6.557700E-03 |
| Grade 1-vs-Grade 3 |
5.838700E-03 |
| Grade 1-vs-Grade 4 |
2.664300E-02 |
| Grade 2-vs-Grade 3 |
1.216640E-01 |
| Grade 2-vs-Grade 4 |
7.016000E-01 |
| Grade 3-vs-Grade 4 |
7.943800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.83983947468869E-12 |
| Normal-vs-ccB subtype |
7.0566996690502E-10 |
| ccA subtype-vs-ccB subtype |
5.232600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.65079999354157E-10 |
| Normal-vs-N1 |
9.413500E-04 |
| N0-vs-N1 |
9.875400E-01 |
|
|
